Nootropil (Piracetam)

Piracetam modulates the fluidity of neuronal membranes, influencing ion channels and receptors such as acetylcholine and glutamate. This improves synaptic transmission, cerebral metabolism, and blood flow, thereby facilitating neuroplasticity and long‑term potentiation, which are essential for learning and memory processes.

The dosage of Nootropil is individualized by the prescribing clinician based on the patient’s condition, age, renal function and response to therapy. Healthcare professionals determine the appropriate strength, frequency and duration of treatment.

Safety data for piracetam in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Nootropil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other racetams such as aniracetam or oxiracetam, piracetam has a well‑established safety profile and is the most widely studied. It generally requires higher doses and may have a milder effect on cognition, but it is often preferred for its extensive clinical experience and lower cost.

Nootropil tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight. This helps maintain potency and prevents degradation.

Nootropil is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or split unless advised by a healthcare professional.

Serious but rare risks include severe allergic reactions such as rash or angioedema, thrombocytopenia, significant mood changes including depression or suicidal thoughts, and paradoxical worsening of seizures. Patients should seek immediate medical attention if any of these occur.

Individuals with known hypersensitivity to piracetam or any excipients in the tablet should avoid Nootropil. Caution is also advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking medications that may interact significantly, such as anticoagulants or CNS depressants.